JP2022529380A5 - - Google Patents
Info
- Publication number
- JP2022529380A5 JP2022529380A5 JP2021563033A JP2021563033A JP2022529380A5 JP 2022529380 A5 JP2022529380 A5 JP 2022529380A5 JP 2021563033 A JP2021563033 A JP 2021563033A JP 2021563033 A JP2021563033 A JP 2021563033A JP 2022529380 A5 JP2022529380 A5 JP 2022529380A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cells
- car
- subject
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025046395A JP2025106309A (ja) | 2019-04-26 | 2025-03-21 | キメラ抗原受容体構築物およびcar-t細胞におけるそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962839175P | 2019-04-26 | 2019-04-26 | |
| US62/839,175 | 2019-04-26 | ||
| PCT/US2020/029768 WO2020219843A1 (en) | 2019-04-26 | 2020-04-24 | Chimeric antigen receptor constructs and their use in car-t cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025046395A Division JP2025106309A (ja) | 2019-04-26 | 2025-03-21 | キメラ抗原受容体構築物およびcar-t細胞におけるそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022529380A JP2022529380A (ja) | 2022-06-21 |
| JP2022529380A5 true JP2022529380A5 (https=) | 2023-04-14 |
Family
ID=72941305
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563033A Pending JP2022529380A (ja) | 2019-04-26 | 2020-04-24 | キメラ抗原受容体構築物およびcar-t細胞におけるそれらの使用 |
| JP2025046395A Pending JP2025106309A (ja) | 2019-04-26 | 2025-03-21 | キメラ抗原受容体構築物およびcar-t細胞におけるそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025046395A Pending JP2025106309A (ja) | 2019-04-26 | 2025-03-21 | キメラ抗原受容体構築物およびcar-t細胞におけるそれらの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12479890B2 (https=) |
| EP (1) | EP3959236A4 (https=) |
| JP (2) | JP2022529380A (https=) |
| CN (1) | CN114269777A (https=) |
| WO (1) | WO2020219843A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018050225A1 (en) * | 2016-09-15 | 2018-03-22 | Yu Di | T-cell immunotherapy |
| TW202332765A (zh) * | 2021-09-20 | 2023-08-16 | 美商英麥提克斯股份有限公司 | 用於t細胞療法之t細胞群體的單核球耗盡 |
| KR20250097810A (ko) * | 2022-09-13 | 2025-06-30 | 가부시키가이샤 사이토-팩토 | 이식을 위한 t 세포 및 이의 제조 방법 |
| WO2024236547A1 (en) * | 2023-05-18 | 2024-11-21 | Inceptor Bio, Llc | Modified phagocytic cells expressing chimeric antigen receptors comprising a herpes virus entry mediator (hvem) co-stimulatory domain and uses thereof |
| WO2026047626A1 (en) * | 2024-08-30 | 2026-03-05 | Inceptor Bio, Llc | Compositions and methods involving immune cells engineered for binding bispecific antibodies for use in cell therapy |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170241877A1 (en) * | 2002-03-11 | 2017-08-24 | Janusz B. Pawliszyn | System and method for desorbing and detecting an analyte sorbed on a solid phase microextraction device |
| EP3074419B1 (en) * | 2013-11-25 | 2018-08-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric antigen receptors to control hiv infection |
| WO2015092024A2 (en) * | 2013-12-20 | 2015-06-25 | Cellectis | Method of engineering multi-input signal sensitive t cell for immunotherapy |
| US20170335281A1 (en) | 2014-03-15 | 2017-11-23 | Novartis Ag | Treatment of cancer using chimeric antigen receptor |
| JP6839074B2 (ja) * | 2014-09-17 | 2021-03-03 | ノバルティス アーゲー | 養子免疫療法のためのキメラ受容体での細胞毒性細胞のターゲティング |
| IL297773B2 (en) | 2014-11-17 | 2024-07-01 | Adicet Bio Inc | Engineered gamma delta t-cells |
| EP3233900A2 (en) * | 2014-12-19 | 2017-10-25 | Dana-Farber Cancer Institute, Inc. | Chimeric antigen receptors and methods of use thereof |
| AU2016323985B2 (en) * | 2015-09-17 | 2022-12-15 | Novartis Ag | CAR T cell therapies with enhanced efficacy |
| IL299616A (en) * | 2016-01-08 | 2023-03-01 | Univ California | Conditionally active heterodimeric polypeptides and methods of using them |
| KR20180118175A (ko) * | 2016-03-04 | 2018-10-30 | 노파르티스 아게 | 다중 키메라 항원 수용체 (car) 분자를 발현하는 세포 및 그에 따른 용도 |
| WO2017172952A1 (en) * | 2016-04-01 | 2017-10-05 | Promab Biotechnologies, Inc. | Flag tagged cd19-car-t cells |
| EP3336107A1 (en) * | 2016-12-15 | 2018-06-20 | Miltenyi Biotec GmbH | Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor |
| JP7280827B2 (ja) * | 2017-01-18 | 2023-05-24 | エクスマ バイオテック コーポレイション | Axlまたはror2に対するキメラ抗原受容体およびその使用方法 |
| CN110615842B (zh) * | 2018-06-20 | 2023-05-09 | 上海隆耀生物科技有限公司 | 一种包含共刺激受体的嵌合抗原受体及应用 |
-
2020
- 2020-04-24 JP JP2021563033A patent/JP2022529380A/ja active Pending
- 2020-04-24 CN CN202080047342.2A patent/CN114269777A/zh active Pending
- 2020-04-24 US US17/605,890 patent/US12479890B2/en active Active
- 2020-04-24 EP EP20796240.8A patent/EP3959236A4/en active Pending
- 2020-04-24 WO PCT/US2020/029768 patent/WO2020219843A1/en not_active Ceased
-
2025
- 2025-03-21 JP JP2025046395A patent/JP2025106309A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022529380A5 (https=) | ||
| CN109485734B (zh) | 一种靶向bcma和cd19的双特异性嵌合抗原受体及其应用 | |
| JP7573441B2 (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| KR102777002B1 (ko) | 항글리피칸-3 항체 및 이의 응용 | |
| CN108373504B (zh) | Cd24特异性抗体和抗cd24-car-t细胞 | |
| JP2022523961A5 (https=) | ||
| CN109651511B (zh) | 一种靶向bcma的嵌合抗原受体及其应用 | |
| CN112912401B (zh) | 抗-l1细胞粘附分子抗体或其抗原结合片段及包含其的嵌合抗原受体 | |
| IL268620B2 (en) | Antibodies against LAG3 pharmaceutical formulations containing them, and their uses for cancer treatment | |
| JP2025106309A5 (https=) | ||
| CN112028996A (zh) | 靶向bcma的单域抗体及其用途 | |
| JP2019525771A5 (https=) | ||
| US11725053B2 (en) | Chimeric antigen receptors comprising a human transferrin epitope sequence | |
| JP2019513370A5 (https=) | ||
| RU2018107802A (ru) | Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин | |
| US20200017588A1 (en) | Modular tetravalent bispecific antibody platform | |
| JP2018528786A5 (https=) | ||
| JP2022542559A5 (https=) | ||
| CN114401989A (zh) | 靶向bcma的抗体及嵌合抗原受体 | |
| WO2019195017A1 (en) | Bcma-car-t cells | |
| CN115232209A (zh) | 靶向gprc5d的抗体及其用途 | |
| RU2018104703A (ru) | Опухолеспецифичное антитело против egfr и его применение | |
| CN114437218B (zh) | 靶向cd276的嵌合抗原受体以及包含其的免疫细胞 | |
| WO2020172641A1 (en) | Artificial immunosurveillance chimeric antigen receptor and cells expressing the same | |
| AU2025204510A9 (en) | Car library and scFv manufacturing method |